Loading clinical trials...
Loading clinical trials...
A Double-Blind, Placebo-Controlled, Parallel Design Phase 3 Study to Assess the Efficacy, Safety, Tolerability, and Pattern of Use of SM-1 in Adult Subjects With a History of Transient Insomnia
Conditions
Interventions
SM-1
Placebo
Start Date
May 1, 2023
Primary Completion Date
December 1, 2023
Completion Date
December 1, 2023
Last Updated
April 17, 2024
NCT00163046
NCT00659100
NCT00666770
NCT04396327
NCT03331042
NCT00594022
Lead Sponsor
Sequential Medicine Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions